Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others.

$3.2B

Market Cap • 12/24/2024

2006

(18 years)
Founded

2013

(11 years ago)
IPO

NASDAQ

Listing Exchange
Flag of US

South San Francisco

Headquarters • California